1. Baquero, F. 1997. Gram-positive resistance: challenge for the development of new antibiotics. J. Antimicrob. Chemother.39(Suppl. A):1-6.
2. Candiani, G., M. Abbondi, M. Borgonovi, G. Romano, and F. Parenti. 1999. In vitro and in vivo antibacterial activity of BI397, a new semi-synthetic glycopeptide antibiotic. J. Antimicrob. Chemother.44:179-192.
3. Centers for Disease Control and Prevention. 2002. Staphylococcus aureus resistant to vancomycin: United States, 2002. Morb. Mortal. Wkly. Rep.51:565-567.
4. Jones, R. N., D. J. Biedenbach, D. M. Johnson, and M. A. Pfaller. 2001. In vitro evaluation of BI397, a novel glycopeptide antimicrobial agent. J. Chemother.13:244-254.
5. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Document M7-A6. National Committee for Clinical Laboratory Standards Wayne Pa.